Biokript Review: Check the Exchange Before You Trade

Biokript describes itself as a hybrid exchange for spot trading, combining features associated with centralized and decentralized platforms. Its homepage promotes one-click buying and selling, trading tools, real-time security updates and a token-linked share of platform revenue. The DEX listing characterizes it as a Uniswap V2 fork on BNB Chain, while another listing describes it as built on Solana. Those descriptions do not line up, so confirm the network in the actual app before connecting a wallet or approving a transaction.

There is also a token-name mismatch to resolve: the project classification identifies BKPT, while the homepage promotes BIOK. Do not assume they are interchangeable. Verify the token contract and network through Biokript's official channels, and be wary of lookalike tokens. The platform advertises automated sniping and anti-rug features, but those claims do not guarantee that a trade or token is safe.

A project whitepaper listing reports a 0.1% fee for both makers and takers. Treat that as a reported rate to verify, not a guarantee that it covers every market or transaction: the current fee schedule and any other charges are not established here. On-chain trades can also involve network gas costs, which are separate from an exchange's trading fee.

Biokript advertises that 50% of trading fees go back to its community through a profit-sharing model. That headline does not explain who qualifies, how the share is calculated, how often it is paid, or whether token holders must meet other conditions. The homepage also promotes Whale NFTs with trading credits, but the applicable terms are not clear. Read the current terms for fee deductions, eligibility, payout mechanics, vesting and credit restrictions before treating revenue share or credits as value you will receive.

Biokript advertises a pending U.S. utility patent application and describes security features including anti-rug mechanisms. A pending patent concerns an invention claim; it is not proof that the exchange is secure, independently tested or approved by a regulator. No audit is listed, so you should not treat the site's security claims as a substitute for an independent review.

The project homepage says the platform has no KYC, but that alone does not explain its custody model or what happens if the service has an outage or dispute. One project-directory listing describes Biokript as non-custodial; that is a single-source claim and should be checked against the app's wallet permissions and terms. Licensing details are not published in the details established here. Start with a small amount only if you understand the transaction permissions, and avoid granting broad token approvals you do not need.

Biokript promotes one-click trading and access through its Biokript Pro platform, but details about supported wallets, device compatibility, transaction speed and available markets are not established here. The project's different chain descriptions make network confirmation especially important. Before trading, check the network selected in the app and compare it with the token contract and wallet transaction details; a mistaken network can make funds difficult or impossible to recover.

The homepage says there is no KYC and provides access to a learning center, rewards and referrals, and trading. Do not infer from the no-KYC claim that every service is available everywhere or that no compliance checks can ever apply. Read the current terms and AML policy, and check local rules before using the platform. For an initial test, use a wallet with limited funds and review each approval and transaction rather than relying on claims of speed or automation.

The biggest issue for a prospective user is not a missing convenience feature but inconsistent core details: the project homepage promotes BIOK, the classification names BKPT, and descriptions point to both BNB Chain and Solana. Resolve those discrepancies before interacting with any token or trading contract. Biokript also does not have an audit listed, and its custody and licensing details are not clearly established.

The claimed 50% revenue share may appeal to token holders, but the payout terms need more detail to judge its value. A reported 0.1% maker/taker fee is not enough to calculate your full cost without the current fee schedule, network costs and any other conditions. If you need a well-documented platform with independently published audits, clear token details and a fully specified fee and payout model, compare alternatives before depositing or approving funds.